Science Translational Medicine Journal Issues Research Articles in March 9, 2022 Edition
March 09, 2022
March 09, 2022
NEW YORK, March 9 -- Science Translational Medicine, a peer-reviewed journal from the American Association for the Advancement of Science that focuses on research in the translational medicine community, published research articles on the following topics in its March 9, 2022 edition:
RESEARCH ARTICLES:
* Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia
* Innate PD-L1 limits T cell-mediated adipose tissue inflammation and ameli . . .
RESEARCH ARTICLES:
* Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia
* Innate PD-L1 limits T cell-mediated adipose tissue inflammation and ameli . . .